These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4052061)

  • 1. Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production.
    Aviram M; Sirtori CR; Colli S; Maderna P; Morazzoni G; Tremoli E
    Biochem Med; 1985 Aug; 34(1):29-36. PubMed ID: 4052061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the effect of plasma lipoproteins on platelet function in vitro.
    Aviram M; Brook JG
    Haemostasis; 1983; 13(6):344-50. PubMed ID: 6421681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of vinblastine on malondialdehyde formation, serotonin release and aggregation in human platelets.
    Brammer JP; Kerecsen L; Maguire MH
    Eur J Pharmacol; 1982 Jul; 81(4):577-85. PubMed ID: 6811295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of blood constituents on platelet function: role of blood cells and plasma lipoproteins.
    Aviram M; Brook JG
    Artery; 1983; 11(4):297-305. PubMed ID: 6615246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arachidonate transfer between platelets and lipoproteins.
    Surya II; Gorter G; Akkerman JW
    Thromb Haemost; 1992 Dec; 68(6):719-26. PubMed ID: 1287888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine modification of LDL or lipoprotein(a) by 4-hydroxynonenal or malondialdehyde decreases platelet serotonin secretion without affecting platelet aggregability and eicosanoid formation.
    Malle E; Ibovnik A; Leis HJ; Kostner GM; Verhallen PF; Sattler W
    Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):377-84. PubMed ID: 7749848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous lipoproteins modify the thromboxane formation capacity of platelets.
    Beitz J; Block HU; Beitz A; Müller G; Winkler L; Dargel R; Mest HJ
    Atherosclerosis; 1986 May; 60(2):95-9. PubMed ID: 3718615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid activation of human platelets by low concentrations of low-density lipoprotein via phosphatidylinositol cycle.
    Knorr M; Locher R; Vogt E; Vetter W; Block LH; Ferracin F; Lefkovits H; Pletscher A
    Eur J Biochem; 1988 Mar; 172(3):753-9. PubMed ID: 3350022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoproteins and the inhibitory effect of human endothelial cells on platelet function.
    Nordøy A; Svensson B; Wiebe D; Hoak JC
    Circ Res; 1978 Oct; 43(4):527-34. PubMed ID: 210972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LDLs increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules.
    van Willigen G; Gorter G; Akkerman JW
    Arterioscler Thromb; 1994 Jan; 14(1):41-6. PubMed ID: 8274476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities in platelets and vascular endothelial cells induced by glycated lipoproteins.
    Takeda H; Yano T; Kishikawa H; Miyata T; Shinohara M; Yamaguchi E; Kobori S; Fan JL; Tokunaga O; Shichiri M
    Intern Med; 1992 Jun; 31(6):746-51. PubMed ID: 1392175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of eicosanoids for arteriosclerosis and the effect of lipoproteins on prostanoid formation].
    Mest HJ; Beitz J
    Z Gesamte Inn Med; 1986 Feb; 41(4):94-8. PubMed ID: 3518258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of prostaglandin synthesis in washed human platelets and cultured bovine aortic endothelial cells by glycosylated low density lipoprotein.
    Ishii H; Umeda F; Kunisaki M; Yamauchi T; Nawata H
    Diabetes Res; 1989 Dec; 12(4):177-82. PubMed ID: 2637093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of a cod liver oil diet in healthy and insulin-dependent diabetic volunteers on fatty acid pattern, inhibition of prostacyclin formation by low density lipoprotein (LDL) and platelet thromboxane.
    Beitz J; Schimke E; Liebaug U; Block HU; Beitz A; Honigmann G; Sziegoleit W; Müller G; Mest HJ
    Klin Wochenschr; 1986 Sep; 64(17):793-9. PubMed ID: 3531705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native lipoproteins inhibit platelet activation induced by oxidized lipoproteins.
    Takahashi Y; Chiba H; Matsuno K; Akita H; Hui SP; Nagasaka H; Nakamura H; Kobayashi K; Tandon NN; Jamieson GA
    Biochem Biophys Res Commun; 1996 May; 222(2):453-9. PubMed ID: 8670226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence on thromboxane and malondialdehyde synthesis in human thrombocytes by various inhibitors of platelet function.
    Busse WD; Seuter F
    Agents Actions Suppl; 1979; (4):127-37. PubMed ID: 291303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective release from platelet granules induced by plasma lipoproteins.
    Aviram M; Brook JG
    Biochem Med; 1984 Aug; 32(1):30-3. PubMed ID: 6208898
    [No Abstract]   [Full Text] [Related]  

  • 19. Abnormal plasma lipoprotein composition in hypercholesterolaemic patients induces platelet activation.
    Viener A; Brook JG; Aviram M
    Eur J Clin Invest; 1984 Jun; 14(3):207-13. PubMed ID: 6432549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihistaminic drug bromadryl and stimulated platelet aggregation.
    Nosál R; Jancinová V; Petríková M
    Agents Actions; 1994 Jun; 41 Spec No():C104-5. PubMed ID: 7976789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.